C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/38 (2006.01) A61K 39/245 (2006.01) A61K 39/25 (2006.01) C07K 14/045 (2006.01) C12N 7/01 (2006.01) C12N 15/66 (2006.01)
Patent
CA 2425202
The invention provides peptides which are immunogenic epitopes recognized by CD8+ class I MHC restricted cytotoxic T-lymphocytes of patients harboring latent cytomegalovirus (HCMV) infection. The peptides are capable of activating CTL in the absence of active viral replication, and thus are useful for eliciting a cellular immune response against HCMV by normal and immunodeficient subjects. Vaccines against HCMV, with and without adjuvants, and immunological and diagnostic reagents are disclosed.
L'invention concerne des peptides qui sont des épitopes immunogéniques reconnus par des lymphocytes T cytotoxiques CD8 + de classe I à restriction au CMH chez les patients couvant une infection latente par le cytomégalovirus (HCMV). Ces peptides, qui sont capables d'activer les CTL en l'absence de réplication virale active, conviennent pour éliciter une réponse immunitaire cellulaire contre le HCMV de la part de sujets normaux et de sujets immunodéficients. L'invention concerne également des vaccins contre le HCMV, avec ou sans adjuvants, ainsi que des réactifs immunologiques et de diagnostic.
City Of Hope
Osler Hoskin & Harcourt Llp
LandOfFree
Immunoreactive peptide ctl epitopes of human cytomegalovirus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoreactive peptide ctl epitopes of human cytomegalovirus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoreactive peptide ctl epitopes of human cytomegalovirus... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1740009